RBC Capital Keeps Their Buy Rating on Penumbra (PEN)

In a report released today, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Penumbra (PEN – Research Report), with a price target of $289.00. The company’s shares closed yesterday at $210.00.

According to TipRanks, Singh Chadha is an analyst with an average return of -0.6% and a 39.68% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Zynex, and Axonics Modulation Technologies.

Penumbra has an analyst consensus of Moderate Buy, with a price target consensus of $279.33, implying a 33.01% upside from current levels. In a report released today, BTIG also maintained a Buy rating on the stock with a $265.00 price target.

The company has a one-year high of $348.67 and a one-year low of $180.93. Currently, Penumbra has an average volume of 368.1K.

Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PEN in relation to earlier this year. Most recently, in March 2024, Adam Elsesser, the CEO & President of PEN bought 5,000.00 shares for a total of $38,750.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Penumbra (PEN) Company Description:

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.